Genetic and environmental factors in Alzheimer's disease

Revue Neurologique

Volumn 155, Issue SUPPL. 4, 1999, Pages

  Tol, J ^a   Roks, G ^a   Slooter, A J C ^a   Van Duijn, C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; REVIEW; RISK FACTOR; AGED; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; COMPARATIVE STUDY; ENVIRONMENT; EXON; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; POINT MUTATION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; ENVIRONMENT; EXONS; GENE EXPRESSION; GENOTYPE; HUMANS; POINT MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0033428612     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. BAUM L, CHEN L, NG HK, CHAN YS, MAK YT, WOO J, CHIU HF & PANG CP. (1998). Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett, 247: 33-6.
2. BEFFERT U, ARGUIN C & POIRIER J. (1999). The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease. Neurosci Lett, 259: 29-32.
3. BLACKER D, WILCOX MA, LAIRD NM, RODES L, HORVATH SM, GO RC, PERRY R, WATSON B JR, BASSETT SS, MCINNIS MG, ALBERT MS, HYMAN BT & TANZI RE. (1998). Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet, 19: 357-60.
4. BRENNER DE, KUKULL WA, STERGACHIS A, VAN BELLE G, BOWEN JD, MCCORMICK WC, TERI L & LARSON EB. (1994). Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol, 140: 262-7.
5. BRETELER MM, CLAUS JJ, GROBBEE DE & HOFMAN A. (1994). Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. Bmj, 308: 1604-8.
6. CLATWORTHY AE, GOMEZ-ISLA T, REBECK GW, WALLACE RB & HYMAN BT. (1997). Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch Neurol, 54: 1289-92.
7. CRUTS M, VAN DUIJN CM, BACKHOVENS H, VAN DEN BROECK M, WEHNERT A, SERNEELS S, SHERRINGTON R, HUTTON M, HARDY J, ST GEORGE-HYSLOP PH, HOFMAN A & VAN BROECKHOVEN C. (1998). Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet, 7:43-51.
8. DAVIGNON J, GREGG RE & SING CF. (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis, 8: 1-21.
9. Dow DJ, LINDSEY N, CAIRNS NJ, BRAYNE C, ROBINSON D, HUPPERT FA, PAYLED ES, XUERED J, WIDCOCK G, et al. (1999). Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat. Genet. In press.
10. FALLIN D, KUNDTZ A, TOWN T, GAUNTLETT AC, DUARA R, BARKER W, CRAWFORD F & MULLAN M. (1997). No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett, 233: 145-7.
11. FARRER LA, CUPPLES LA, HAINES JL, HYMAN B, KUKULL WA, MAYEUX R, MYERS RH, PERICAK-VANCE MA, RISCH N & VAN DUIJN CM. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama, 278: 1349-56.
12. GOATE A, CHARTIER-HARLIN MC, MULLAN M, BROWN J, CRAWFORD F, FIDANI L, GIUFFRA L, HAYNES A, IRVING N, JAMES L et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349: 704-6.
13. GROWDON JH, LOCASCIO JJ, CORKIN S, GOMEZ-ISLA T & HYMAN BT. (1996). Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology, 47: 444-8.
14. HARDY J & ISRAEL A. (1999). Alzheimer's disease. In search of gamma-secretase. Nature, 398: 466-7.
15. HENDERSON VW. (1999). The Epidemiology of Alzheimer's Disease: The Role of Estrogen in Reducing Risk. In Mayeux R, Christen Y (eds.), Epidemiology of Alzheimer's Disease: From Gene to Prevention, pp. 49-63. Springer-Verlag, Heidelberg.
16. HOFMAN A, OTT A, BRETELER MM, BOTS ML, SLOOTER AJ, VAN HARSKAMP F, VAN DUIJN CN, VAN BROECKHOVEN C & GROBBEE DE. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet, 349: 151-4.
17. HOLLENBACH E, ACKERMANN S, HYMAN BT & REBECK GW. (1998). Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology, 50: 1905-7.
18. KAMBOH MI, FERRELL RE & DEKOSKY ST. (1998). Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett, 244: 65-8.
19. KANG DE, SAITOH T, CHEN X, XIA Y, MASLIAH E, HANSEN LA, THOMAS RG, THAL LJ & KATZMAN R. (1997). Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology, 49: 56-61.
20. KAWAS C, RESNICK S, MORRISON A, BROOKMEYER R, CORRADA M, ZONDERMAN A, BACAL C, LINGLE DD & METTER E. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology, 48: 1517-21.
21. LAMBERT JC, WAVRANT-DE VRIEZE F, AMOUYEL P & CHARTIER-HARLIN MC. (1998). Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet, 351: 1787-8.
22. LENDON CL, TALBOT CJ, CRADDOCK NJ, HAN SW, WRAGG M, MORRIS JC & GOATE AM. (1997). Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett, 222: 187-90.
23. LIAO A, NITSCH RM, GREENBERG SM, FINCKH U, BLACKER D, ALBERT M, REBECK GW, GOMEZ-ISLA T, CLATWORTHY A, BINETTI G, HOCK C, MUELLER-THOMSEN T, MANN U, ZUCHOWSKI K, BEISIEGEL U, STAEHELIN H, GROWDON JH, TANZI RE & HYMAN BT. (1998). Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet, 7: 1953-6.
24. MAHLEY RW. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 240: 622-30.
25. MAYEUX R, STERN Y, OTTMAN R, TATEMICHI TK, TANG MX, MAESTRE G, NGAI C, TYCKO B & GINSBERG H. (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol, 34: 752-4.
26. OSUNTOKUN BO, SAHOTA A, OGUNNIYI AO, GUREJE O, BAIYEWU O, ADEYINKA A, OLUWOLE SO, KOMOLAFE O, HALL KS, UNVERZAGT FW et al. (1995). Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann Neurol, 38: 463-5.
27. PERICAK-VANCE MA, BASS MP, YAMAOKA LH, GASKELL PC, SCOTT WK, TERWEDOW HA, MENOLD MM, CONNEALLY PM, SMALL GW, VANCE JM, SAUNDERS AM, ROSES AD & HAINES JL. (1997). Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. Jama, 278: 1237-41.
28. PERICAK-VANCE MA, YAMAOKA LH, HAYNES CS, SPEER MC, HAINES JL, GASKELL PC, HUNG WY, CLARK CM, HEYMAN AL, TROFATTER JA et al. (1988). Genetic linkage studies in Alzheimer's disease families. Exp Neurol, 102: 271-9.
29. ROGAEV EI, SHERRINGTON R, ROGAEVA EA, LEVESQUE G, IKEDA M, LIANG Y, CHI H, LIN C, HOLMAN K, TSUDA T et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376: 775-8.
30. ROGAEVA E, PREMKUMAR S, SONG Y, SORBI S, BRINDLE N, PATERSON A, DUARA R, LEVESQUE G, Yu G, NISHIMURA M, IKEDA M, O'TOOLE C, KAWARAI T, JORGE R, VILARINO D, BRUNI AC, FARRER LA & ST GEORGE-HYSLOP PH. (1998). Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. Jama, 280: 614-8.
31. ROGAEVA EA, PREMKUMAR S, GRUBBER J, SERNEELS L, SCOTT WK, KAWARAI T, SONG Y, HILL DL, ABOU-DONIA SM, MARTIN ER, VANCE JJ, Yu G, ORLACCHIO A, PEI Y, NISHIMURA M, SUPALA A, ROBERGE B, SAUNDERS AM, ROSES AD, SCHMECHEL D, CRANE-GATHERUM A, SORBI S, BRUNI A, SMALL GW, PERICAK-VANCE MA et al. (1999). An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet, 22: 19-22.
32. ROTHMAN KJ. (1986). Moderen epidemiology. Little, Brown and company, Boston/Toronto.
33. RUDRASINGHAM V, WAVRANT-DE VRIEZE F, LAMBERT JC, CHAKRAVERTY S, KEHOE P, CROOK R, AMOUYEL P, WU W, RICE F, PEREZ-TUR J, FRIGARD B, MORRIS JC, CARTY S, PETERSEN R, COTTEL D, TUNSTALL N, HOLMANS P, LOVESTONE S, CHARTIER-HARLIN MC, GOATE A, HARDY J, OWEN MJ & WILLIAMS J. (1999). Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet, 22: 17-9; discussion 21-2.
34. SCHELLENBERG GD, BIRD TD, WIJSMAN EM, MOORE DK, BOEHNKE M, BRYANT EM, LAMPE TH, NOCHLIN D, SUMI SM, DEEB SS et al. (1988). Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science, 241: 1507-10.
35. SCHELLENBERG GD, PERICAK-VANCE MA, WIJSMAN EM, MOORE DK, GASKELL PC JR, YAMAOKA LA, BEBOUT JL, ANDERSON L, WELSH KA, CLARK CM et al. (1991). Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am J Hum Genet, 48: 563-83.
36. SELKOE DJ. (1995). Alzheimer's Disease. Missense on the membrane. Nature, 375: 734-5.
37. SLOOTER AJ, BRETELER MB, OTT A, VAN BROECKHOVEN C & VAN DUIJN CM. (1996). APOE genotyping in differential diagnosis of Alzheimer's disease. Lancet, 348: 334.
38. SLOOTER AJ & VAN DUIJN CM. (1997). Genetic epidemiology of Alzheimer disease. Epidemiol Rev, 19: 107-19.
39. ST GEORGE-HYSLOP PH, HAINES JL, FARRER LA, POLINSKY R, VAN BROECKHOVEN C, GOATE A, MCLACHLAN DR, ORR H, BRUNI AC, SORBI S et al. (1990). Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature, 347: 194-7.
40. STRITTMATTER WJ, SAUNDERS AM, SCHMECHEL D, PERICAK-VANCE M, ENGHILD J, SALVESEN GS & ROSES AD. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA, 90: 1977-81.
41. TANG MX, JACOBS D, STERN Y, MARDER K, SCHOFIELD P, GURLAND B, ANDREWS H. & MAYEUX R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348: 429-32.
42. TANZI RE, ST GEORGE-HYSLOP PH, HAINES JL, POLINSKY RJ, NEE L, FONCIN JF, NEVE RL, MCCLATCHEY AI, CONNEALLY PM & GUSELLA JF. (1987). The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature, 329: 156-7.
43. TOL J, SLOOTER AJC, VAN DUIJN CM. (1999). Genetic factors in early-and late-onset Alzheimer's disease. In Mayeux R & Christen Y (eds). Epidemiology of Alzheimer's Disease: From Gene to Prevention, pp. 32-39. Springer-Verlag, Heidelberg.
44. VAN BROECKHOVEN C, BACKHOVENS H, CRUTS M, MARTIN JJ, CROOK R, HOULDEN H & HARDY J. (1994). APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett, 169: 179-80.
45. VAN BROECKHOVEN C, GENTHE AM, VANDENBERGHE A, HORSTHEMKE B, BACKHOVENS H, RAEYMAEKERS P, VAN HUL W, WEHNERT A, GHEUENS J, CRAS P et al. (1987). Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature, 329: 153-5.
46. VAN BROECKHOVEN CL. (1995). Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol, 35: 8-19.
47. VAN DUIJN CM. (1996). Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry, 60: 478-88.
48. VAN DUIJN CM. (1997). Menopause and the brain. J Psychosom Obstet Gynaecol, 18: 121-5.
49. VAN DUIJN CM, CLAYTON D, CHANDRA V, FRATIGLIONI L, GRAVES AB, HEYMAN A, JORM AF, KOKMEN E, KONDO K, MORTIMER JA et al. (1991). Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol, 20: S13-20.
50. VAN DUIJN CM, DE KNIJFF P, CRUTS M, WEHNERT A, HAVEKES LM, HOFMAN A & VAN BROECKHOVEN C. (1994). Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet, 7: 74-8.
51. WAVRANT-DE VRIEZE F, PEREZ-TUR J, LAMBERT JC, FRIGARD B, PASQUIER F, DELACOURTE A, AMOUYEL P, HARDY J & CHARTIER-HARLIN MC. (1997). Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett, 227: 68-70.
52. WAVRANT-DE VRIEZE F, RUDRASINGHAM V, LAMBERT JC, CHAKRAVERTY S, KEHOE P, CROOK R, AMOUYEL P, Wu W, HOLMANS P, RICE F, PEREZ-TUR J, FRIGARD B, MORRIS JC, CARTY S, COTTEL D, TUNSTALL N, LOVESTONE S, PETERSEN RC, CHARTIER-HARLIN MC, GOATE A, OWEN MJ, WILLIAMS J & HARDY J. (1999). No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci Lett, 262: 137-9.
53. WOODWARD R, SINGLETON AB, GIBSON AM, EDWARDSON JA & MORRIS CM. (1998). LRP gene and late-onset Alzheimer's disease. Lancet, 352: 239-40.
54. WU WS, HOLMANS P, WAVRANT-DE VRIEZE F, SHEARS S, KEHOE P, CROOK R, BOOTH J, WILLIAMS N, PEREZ-TUR J, ROEHL K, FENTON I, CHARTIER-HARLIN MC, LOVESTONE S, WILLIAMS J, HUTTON M, HARDY J, OWEN MJ & GOATE A. (1998). Genetic studies on chromosome 12 in late-onset Alzheimer disease. Jama, 280: 619-22.